Jove
Visualize
Contact Us

Related Concept Videos

Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

632
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
632
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

665
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
665
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

13.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.7K
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

1.2K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.2K
Two-Compartment Open Model: IV Bolus Administration01:18

Two-Compartment Open Model: IV Bolus Administration

1.1K
The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
1.1K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

2.7K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world outcomes using the Tandem Mobi insulin pump with Control-IQ+ technology and Dexcom G7.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Correction to: The BSSPD 2025 debate: sustainability of dentistry and prosthodontics - is this an emergency?

British dental journal·2026
Same author

First Use of Control-IQ+ Technology in Newly Indicated Populations.

Diabetes technology & therapeutics·2026
Same author

Cortical Activity Associated With Phantom Leg Movements.

IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society·2026
Same author

Exploring User Experiences With the Lift App for Emotional Well-Being Among Youth With Type 1 Diabetes: Qualitative Study.

JMIR diabetes·2026
Same author

The BSSPD 2025 debate: sustainability of dentistry and prosthodontics - is this an emergency?

British dental journal·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 11, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.3K

Fully Closed-Loop Insulin Delivery with High-Carbohydrate and High-Fat Meals Using the Tandem Freedom System.

Tom M Wilkinson1, Martin I de Bock1, Renee Meier1

  • 1Department of Paediatrics, University of Otago, Christchurch, New Zealand.

Journal of Diabetes Science and Technology
|November 14, 2025
PubMed
Summary

A new fully closed-loop (FCL) system effectively managed type 1 diabetes (T1D) during unannounced high-fat, high-carbohydrate meals. This advanced FCL insulin delivery demonstrated safety and improved time in range for T1D patients.

Keywords:
DKATandemautomated insulin deliveryfreedomfully closed loophybrid closed loophyperglycemiahypoglycemiatype 1 diabetes

More Related Videos

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

10.8K
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

95.6K

Related Experiment Videos

Last Updated: Jan 11, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.3K
Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

10.8K
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

95.6K

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Diabetes Technology

Background:

  • Type 1 diabetes (T1D) management presents challenges, particularly with unannounced high-carbohydrate and high-fat meals.
  • Evaluating advanced automated insulin delivery systems is crucial for improving glycemic control in T1D.

Purpose of the Study:

  • To assess the efficacy and safety of a new fully closed-loop (FCL) insulin delivery system.
  • To evaluate FCL system performance in adults with T1D consuming unannounced high-carbohydrate and high-fat meals.

Main Methods:

  • Ten adults with T1D participated in a 72-hour hotel study using the Tandem Freedom FCL System.
  • Participants consumed unannounced high-carbohydrate and high-fat meals and underwent daily exercise challenges.
  • Outcomes were compared to a 1-week run-in period using a standard control system with mealtime boluses.

Main Results:

  • The FCL system was active 97.3% of the time, with no diabetic ketoacidosis or severe hypoglycemia events.
  • Median time in range (TIR) 70-180 mg/dL was 61.0% during FCL use versus 56.3% during the run-in period.
  • Overnight TIR significantly improved with FCL (95.9%) compared to the run-in period (69.6%), with low time below 70 mg/dL (0.4%).

Conclusions:

  • The Tandem Freedom FCL system demonstrated safety and effectiveness in adults with T1D.
  • FCL insulin delivery successfully managed glycemic control during challenging meal conditions without meal announcement or boluses.